Dividend Policy :
The Company is a research-driven biotechnology enterprise that emphasizes long-term technological development and product innovation.
Before achieving stable profitability, earnings will primarily be reinvested in research and development as well as business expansion to strengthen the Company’s competitiveness.
In the future, depending on R&D progress and financial performance, the Company will consider appropriate distributions of dividends in cash or stock to reward shareholders.
